Credit Suisse’s NeueHealth NEUE Stock Holding History

Credit Suisse’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3	Closed	-$155	–	3772
2022 Q4	$155	Sell	3 -11	-79%	-$800	﹤0.01%	3606
2022 Q3	$1K	Buy	+14	New	+$1.86K	﹤0.01%	3952
2022 Q2	–	Hold	0	–	–	–	4375

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

MCAV

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse's NEUE Position: Q1 2023 in Review

Credit Suisse sold out of NeueHealth (NEUE) in Q1 2023, closing a stake of 3 shares — an estimated $155 sold.

Credit Suisse first reported a position in NEUE in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 108 funds tracked by Wall St. Rank hold NEUE as of Q1 2023.

Credit Suisse reported no remaining NeueHealth position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 3 NeueHealth shares in Q1 2023, an estimated $155.
Credit Suisse first reported a position in NeueHealth in Q3 2022 and held it in 2 quarters.
Credit Suisse's NeueHealth position peaked at $1K in Q3 2022.
108 funds tracked by Wall St. Rank held NeueHealth as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.